Clinical Trials Browser

Phase 2 × INDUSTRY × Peripheral Nervous System Diseases × Clear all

NCT06848348 2026-05-29

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Phase 2 Recruiting

BreastGastrointestinal

Cancer Pain, Breast Neoplasms, Neoplasms, Neuralgia, Pain, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT05488873 2024-07-22

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

Phase 2 Active not recruiting

Neoplasms, Peripheral Nervous System Diseases

NCT04675450 2023-06-08

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Phase 2 Withdrawn

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Phase 2 Completed

GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

NCT00267007 2014-06-04

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Phase 2 Terminated

32 enrolled 9 charts

Neoplasms, Peripheral Nervous System Diseases

NCT00041795 2005-06-24

Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Phase 2 Completed

Peripheral Nervous System Diseases